Gloucestershire Health and Care- NHS Trust logo
with you, for you

Search for a reference number

MH Services

064-2024

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: –
1.Please supply patient’s information ECT leaflet
2.Please supply patient ECT consent form
3.Please supply any ECT reports/investigations
4.How many ECT in 2023?
5.What proportion of patients were men/women?
6.How old were they?
7.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
8.How many people covered by the equality act received ECT ?
9.How many people were offered talking therapy prior to ECT ?
10.How many were receiving ECT for the first time?
11.How many patients consented to ECT?
12.How many ECT complaints were investigated outside the NHS and CCG?
13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?
14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?
15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?
16.How many patients have suffered complications during and after ECT and what were those complications?
17.Have there been any formal complaints from patients/relatives about ECT?
18.If so, what was their concerns?
19.How many patients report memory loss/loss of cognitive function?
20.What tests are used to assess memory loss/loss of cognitive function?
21.Have MRI or CT scans been used before and after ECT?
22.If so, what was the conclusion?
23.How does the Trust plan to prevent ECT in the future?

Please provide restraints information under the FOI act to the following questions: –
1.Please supply any Restraints/investigations
2.How many RESTRAINTS in 2023?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act were restrained?
7.How many RESTRAINTS were investigated outside the NHS and CCG?
8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?
11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?
12.Have there been any formal complaints from patients/relatives about RESTRAINTS?
13.If so, what was their concerns?
14.Are counts of forced injections available?
15.How does the Trust plan to reduce restraints in the future?

Please provide SECLUSION information under the FOI act to the following questions: –
1.Please supply any SECLUSION reports/investigations
2.How many SECLUSIONS in 2023?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the Equality Act were secluded ?
7.How many SECLUSIONS were investigated outside the NHS and CCG?
8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?
11.How many patients have suffered complications during and after SECLUSION and what were those complications?
12.Have there been any formal complaints from patients/relatives about SECLUSION?
13.If so, what was their concerns?
14.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions: –
1.Please supply any MEDICATION ERRORS reports/investigations
2.How many MEDICATION ERRORS in 2023?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act endured medication errors ?
7.How many MEDICATION ERRORS were investigated outside the NHS and CCG?
8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?
11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?
12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?
13.If so, what was their concerns?
14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

read more

212-2024

1 (a) In the last 12 months (of data), in total how many patients with Schizophrenia and other non-mood disorders (F20-F29 inclusive) were managed by your Trust.
1 (b) In the last 12 months (of data), in total how many patients diagnosed Schizophrenia (F20 only) were managed by your Trust.

2 (a) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders have been treated within each of the following services:
• Early Intervention Psychosis service team
• Community Mental Health Team

2 (b) In the last 3 months (of data), how many patients with Schizophrenia had no change to the antipsychotic medication within each of the following services. This includes patients with no change in dose.
• Early Intervention Psychosis service team
• Community Mental Health Team

3 (a) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders were discharged to primary care from each of the following services?
• Early Intervention Psychosis service team
• Community Mental Health Team

3 (b) In the last 12 months (of data), how many patients with Schizophrenia and other non-mood disorders were discharged from the Early Intervention Psychosis service team to the Community Mental Health Team

read more

233-2024

1. The number of individuals who have received support or counselling related to fireworks (e.g., anxiety, trauma, or phobias triggered by fireworks).

2. The data categorised by:
1. Age
2. Gender
3. Year (2021, 2022, 2023, and 2024).
4. Month
5. If possible, broken down by condition:
i. Anxiety, Trauma, Depression, PTSD, Phobia, Ligyrophobia (also spelled Ligurophobia or Phonophobia).

read more

179-2024

For each of the last three calendar years (2022, 2023, and 2024) could you please provide me with:
1. the number of mental health patients who have been physically restrained;
2. the individual number of restraint incidents per patient on average;
3. the number that involved face-down restraint;
4. the number of patient injuries as a result of any physical restraint; and
5. the number of staff injuries as a result of any physical restraint.

read more

193-2024

Overview of Services:
A comprehensive list of all services and programmes currently offered specifically for people with co-existing mental health and substance use needs.
Details on whether these services are integrated (addressing both issues simultaneously) or if they operate separately.
Access and Eligibility:
The eligibility criteria for accessing these services.
Information on referral processes, including whether self-referrals are accepted.
Performance and Outcomes:
Copies of any evaluations, audits, or performance reports related to these services from the past three years.
Key performance indicators used to measure the effectiveness of the services.
Partnerships and Collaborations:
Information on any partnerships with other organisations (e.g., NHS trusts, charities, community groups) in delivering these services.
Details of joint initiatives or programmes aimed at supporting this client group.
Future Developments:
Any planned changes, expansions, or reductions to these services in the next 12 months.
Strategies in place to improve service delivery for individuals with co-existing mental health and substance use needs.
Access and Eligibility:
Average waiting times from referral to initial assessment and from assessment to commencement of treatment.
Service Capacity and Utilisation:
The total number of individuals who have accessed these services in the past three years, broken down by year.
The maximum capacity of each service or programme.
The number of staff dedicated to these services, including their professional qualifications.
Staffing and Expertise:
Details of any specialised training provided to staff for working with co-existing conditions.
Funding and Resources:
The annual budget allocated to these services for the past three financial years.
Information on any funding changes during this period and the reasons for such changes.

read more

178-2024

I am making a Freedom of Information Request for both ICD10 first diagnosis discharge codes and cases (and the same for OPCS codes and cases if you have any), recorded per individual facility in your health authority.
Any information must be totally anonymised.
I am requesting the data for the last five calendar years, i.e. 2018, 2019, 2020, 2021, 2022, 2023.
The suggested data format is in columns:
1. Facility name
2. Primary diagnosis ICD-10 4 or 5 digits (The ICD 10 data set I am asking for comprises the range A000 to Q999)
3. (all OPCS codes)
4. Number of cases
5. Years

read more